The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension
Lydtin, H.
Die Medizinische Welt 6(35): 1487-1492
1975
ISSN/ISBN: 0025-8512 PMID: 240998 Document Number: 94962
Document emailed within 1 workday
Related Documents
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335Lenders, J.W.; Thien, T. 1984: Cold hands and feet in the treatment of hypertension with beta receptor blocking agents Nederlands Tijdschrift Voor Geneeskunde 128(49): 2318-2321
Madan, B.R.; Gupta, R.S. 1970: Effect of adrenergic beta receptor blocking agents on cardiac output Indian Heart Journal 22(2): 70-72
Hoffmann, J.; Schrey, A.; Grund, R.; Forst, T. 1981: Combination of beta-receptor blocking agents and saluretica in outpatient treatment of hypertension. Results of a comparative study Münchener Medizinische Wochenschrift 123(12): 483-488
Nosál', R.; Drábiková, K.; Pecivová, J. 1988: Adverse effects of beta-adrenergic receptor blocking agents on the cellular level Casopis Lekaru Ceskych 127(5): 133-136
Bellomo, G.; Santucci, S.; Murrone, A.; Santambrogio, L.; Gennari, M.; Stangoni, G. 1988: Effects of calcium antagonists and beta-adrenergic receptor blocking agents on cardiovascular rhythmicity Panminerva Medica 30(4): 236-239
Singh, K.P. 1979: Modification of hexobarbitone sodium-induced hynosis in mice by beta adrenergic receptor blocking agents Indian Journal of Physiology and Pharmacology 23(1): 52-54
Batlle, F.; Carreño, C.A.; Guetta, N.J.; Vassolo, E.; Bertolasi, C.A. 1970: Treatment of cardiac arrhythmias using a beta adrenergic receptor blocking drug Prensa Medica Argentina 57(38): 1801-1808
Frick, M.H.; Hartikainen, M.; Pörsti, P. 1978: Penbutolol, a new non-selective beta-adrenergic blocking compound in the treatment of hypertension. A comparision with propranolol Annals of Clinical Research 10(2): 105-106
Shen, J.Q. 1981: Atenolol, a new beta-adrenergic blocking agent, in treatment of hypertension: therapeutic effect and hemodynamic changes Zhonghua Xin Xue Guan Bing Za Zhi 9(2): 94-98
Stienstra, R.; de Leeuw, P.W. 1980: Anesthesia in patients under treatment with beta-receptor blocking agents Nederlands Tijdschrift Voor Geneeskunde 124(44): 1878-1881
Metelitsa, V.I.; Filatova, N.P. 1990: Role of a beta adrenergic blocking agent nadolol (corgard) in prevention of arterial hypertension: a 6-month treatment (cooperative study) Kardiologiia 30(5): 8-14
Limon, L. 1990: The use of alpha 1 adrenergic blocking agents for hypertension American Pharmacy 30(6): 54-58
Colace, F. 1970: Pharmacology and clinical use of adrenergic beta-blocking agents Il Policlinico. Sezione Pratica 77(20): 645-656
Canale, J.M.; Horwitz, S. 1979: Therapeutic scope of beta-adrenergic blocking agents Archivos de Investigacion Medica 10(4): 261-277
Holland, M.G. 1974: Autonomic drugs in ophthalmology: Some problems and promises. Section IV: Sympatholytic and sympathetic blocking agents--alpha adrenergic antagonists and beta adrenergic antagonists Annals of Ophthalmology 6(11): 1139-1142
Bühler, F.R.; Lütold, B.E. 1976: Beta adrenergic receptor blockade as a basis for the treatment of hypertension Therapeutische Umschau. Revue Therapeutique 33(5): 336-346
Gáti, T.; Keszler, P.; Zelles, T.; Pucsok, J. 1971: Effect of adrenergic receptor blocking agents on the development of experimental ulcer in the rat Acta Physiologica Academiae Scientiarum Hungaricae 40(3): 393-396
Tafreshi, M.J.; Weinacker, A.B. 1999: Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma PharmacoTherapy 19(8): 974-978
Chan, P.S.; Ellenbogen, L. 1974: New evidence for the beta-adrenergic receptor blocking activity of dihydroergotamine Archives Internationales de Pharmacodynamie et de Therapie 209(2): 204-213